Revvity EV/EBIT RVTY

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2011.

Today, Oct 23, 2026: 46.0×
10-year median: 32.5×
Against its 10-year history: 98th; percentile: 0 is its lowest day, 100 its highest
10-year range: 12.3× to 48.7×
Peer median: 30.9×

Revvity's EV/EBIT is 46.0× as of Oct 23, 2026.

That is above its ten-year median of 32.5×, higher than on 98% of days in the last ten years.

Over that time it ranged from 12.3× in Jun 2021 to 48.7× in Aug 2024.

The median for 10 diagnostics and research stocks of a similar size is 30.9×.

EV/EBIT over time

median 32.5×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	46.0×	29.3×	46.0×
2025	34.3×	29.4×	44.0×
2024	39.6×	37.9×	48.7×
2023	44.2×	21.9×	44.2×
2022	24.0×	17.0×	24.0×
2021	19.6×	12.3×	31.8×
2020	28.8×	26.2×	41.0×
2019	35.6×	30.5×	39.7×
2018	33.7×	30.7×	43.0×
2017	30.8×	23.1×	30.9×
2016	23.3×	22.4×	30.6×
2015	32.9×	20.3×	33.6×
2014	20.6×	19.1×	29.7×
2013	28.1×	24.3×	42.9×
2012	38.2×	14.7×	40.5×
2011	14.0×	12.3×	17.0×

Against its peers

Companies in Medical - Diagnostics & Research nearest Revvity's size, closest first, today.

Company	EV/EBIT
RVTYRevvity	46.0×
MEDPMedpace	31.4×
LHLabcorp	21.6×
DGXQuest Diagnostics	19.5×
BIOBio-Rad Laboratories	40.2×
MTDMettler-Toledo International	30.5×
CAICaris Life Sciences	56.4×
ILMNIllumina	47.7×
IDXXIDEXX Laboratories	30.3×
WATWaters	129×
IQVIQVIA	27.3×
Peer median	30.9×

Where Revvity ranks

#20of 25Diagnostics and research stocks with the lowest EV/EBIT

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Revvity

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.